Table 4.
Effects of SIL, GNPs, and SGNPs on serum liver function parameters.
| Groups | Parameters | ||||
|---|---|---|---|---|---|
| AST (U/L) |
ALT (U/L) |
ALP (U/L) |
Total Bilirubin (mg/dL) | Albumin (g/dL) |
|
| Control | 111.5 d ± 12.44 | 43.33 d ± 7.42 | 101.3 d ± 13.79 | 0.40 c ± 0.10 | 4.11 a ± 0.21 |
| CCl4 | 195.5 a ± 17.76 | 130.8 a ± 13.70 | 252.2 a ± 19.62 | 1.15 a ± 0.30 | 3.14 c ± 0.13 |
| CCl4+SIL | 134.3 bcd ± 12.75 | 61.17 c ± 9.02 | 148.7 c ± 16.72 | 0.75 b ± 0.21 | 3.49 bc ± 0.24 |
| CCl4+GNPs | 159.0 b ± 15.10 | 104.7 b ± 8.91 | 189.0 b ± 16.42 | 0.83 b ± 0.12 | 3.27 bc ± 0.27 |
| CCl4+SGNPs | 125.0 cd ± 10.14 | 51.8 cd ± 6.77 | 133.5 c ± 12.58 | 0.67 bc ± 0.10 | 3.60 b ± 0.08 |
Data are expressed as mean ± SD (n = 6). Means of the groups in the same column with the same superscript letter are not significantly differedent while the means of the groups with different superscript letter are significantly differed (p ≤ 0.05) by ANOVA test using Post Hoc Test (Tukey). AST, aspartate transferase; ALT, alanine transaminase; ALP, alkaline phosphatase.